Ticker: HRMY

Company Overview: Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) focuses on developing treatments for rare neurological diseases. The company has seen growth in its portfolio, particularly with its lead product, WAKIX, which is used in the treatment of narcolepsy. Recent Developments: - In Oct...

Company Overview: Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) continues to expand its footprint in the neuroscience sector, particularly in treating rare neurological diseases. The company focuses on innovative treatments, with its leading product, WAKIX, approved for sleep-related disorder...